Emil Billbäck

DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark

HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.

Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden.

Nycomed Pharma Holding A/S operates as a holding company with an interest in manufacturing generic drugs. It is active in therapeutic areas, such as cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. The company develops, manufactures, and markets products through Nycomed Pharma A/S. Nycomed Pharma Holding is headquartered in Roskilde, Denmark.

ConvaTec, Inc. engages in the manufacture of medical products and technologies focused on therapies for the management of chronic conditions. It specializes in the wound care, ostomy care, continence and critical care, and infusion devices. The company was founded in 1978 and is headquartered in Bridgewater, NJ.

Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.

Nyco Holdings 2 ApS manufactures and markets pharmaceutical products. The company's products include Calcichew D3 for osteoporosis, Angiox for cardiology, Tachosil and Beriplast P for tissue management. The firm was founded in 1874 and is headquartered in Roskilde, Denmark.

Kibion AB manufactures and distributes medical test and analytical instruments. It provides solutions for rapid urea breath tests for diagnosing the stomach ulcer bacterium Helicobacter pylori. The firm offers products such as Heliprobe System, Diabact Urea Breath Test, and Kibion Dynamic. The company was founded in 2005 and is headquartered in Uppsala, Sweden.

Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland.

Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company.

Acino Pharma AG engages in the development, production, and distribution of chemical and pharmaceutical products. It also acquires, manages, and sells participating interests in firms, real estate, and intellectual property rights. The company was founded in 1961 and is headquartered in Liesberg, Switzerland.

Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY.

Burner International A/S manufactures and supplies fire starters for bonfires, barbecues, fireplaces, and wood-burning stoves. The private company is based in Brøndby, Denmark.

Part of BONESUPPORT HOLDING AB, Bone Support Incentive AB provides real estate services. The company is based in Lund, Sweden.

Ortopedservice i Stockholm Ortopedingenjören AB provides a range of orthopedic products like foot beds, bandages, and other rehabilitation products and medical pedicure. The firm manufactures product for musculoskeletal disorders. It sells shoes and casual shoes; boots; Running shoes; sandals; sport protection; socks; accessories; and walking shoes. The company was founded by Carl Wiklund in 1995 and is headquartered in Stockholm, Sweden.

Lakartid Nu Nordic AB operates a hospital.

Oberoende Forsakringar I Sverige AB provides insurance services. The private company is based in Sweden.

Part of Lary 1 AB, Lary 3 AB functions as an investment holding Swedish company. The company is based in Malmö, Sweden.

Moroxite AB is a medtech company based in Lund, Sweden, with subsidiaries in Sweden. Moroxite is developing a portfolio of breakthrough therapies in targeted drug delivery, using innovative nano and micro technology-based platforms. The Swedish company's focus areas include bone regeneration, tumor, and bone infection. The private company has developed a platform for prolonged release of apatite binding drugs, using a carrier containing nano and micro particles. Recently, Moroxite spun-off its bone infection and fracture fixation businesses into independent companies, Moroxite I AB and Moroxite F AB, respectively. Moroxite F AB has raised capital of 10 MSEK in a private placement from two investors, Fåhraeus Startup & Growth and Almi Invest. The company was founded in 2020 by Lars Ã…ke Alvar Lidgren, Magnus Tägil, and Deepak Raina.